Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01267617 · ClinicalTrials.gov registry record

Measuring Cardiovascular Stress in Patients on Hemodialysis

A clinical trial of Hypotension and Hemodialysis, sponsored by West Penn Allegheny Health System.

Completed
Registry status
26
Enrollment target
1
Study location

NCT01267617: Completed study of Hypotension and Hemodialysis, sponsored by West Penn Allegheny Health System.

NCT01267617 is a study of Hypotension and Hemodialysis that has completed, run by West Penn Allegheny Health System. The registered enrollment target is 26 participants, below the 78-participant average among 12 other Hypotension trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01267617, a study of Hypotension and Hemodialysis, has completed, sponsored by West Penn Allegheny Health System.

COMPLETED
Registry status
26 participants
Enrollment target
1
Study location

Study Summary

To determine if proprietary software that uses pulse-wave analysis to interpret the output of a conventional pulse-oximeter, can predict the onset of circulatory stress, before changes in blood pressure and pulse occur, in patients undergoing outpatient hemodialysis.

Primary Outcome

Pulse-wave analysis of an oximeter signal

Study Locations (1)

Pennsylvania

  • Allegheny General Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2010-11-30
Est. Completion 2011-11-14
West Penn Allegheny Health System

14 total trials

What the finished NCT01267617 record still lists

NCT01267617 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 78-participant average among 12 other Hypotension trials with a reported enrollment target (67% lower).

The record links to 4 conditions, with Hypotension appearing as the primary indexed condition, and to 0 interventions.

NCT01267617 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01267617 about?

NCT01267617 is a clinical study titled "Measuring Cardiovascular Stress in Patients on Hemodialysis". To determine if proprietary software that uses pulse-wave analysis to interpret the output of a conventional pulse-oximeter, can predict the onset of circulatory stress, before changes in blood pressure and pulse occur, in patients undergoing outpatient hemodialysis.

What is the current status of trial NCT01267617?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2010-11-30. Estimated completion is 2011-11-14.

What conditions does trial NCT01267617 study?

This clinical trial studies the following conditions: Hypotension, Hemodialysis, Circulatory Stress, Photo-plethysmography.

Who is sponsoring clinical trial NCT01267617?

This trial is sponsored by West Penn Allegheny Health System, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01267617 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypotension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01267617's enrollment target sits among peer trials

26 10th of 12 higher than 3 of 12 other Hypotension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypotension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01267617, the US trial registry maintained by the National Library of Medicine. NCT01267617 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.